<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03312127</url>
  </required_header>
  <id_info>
    <org_study_id>14 7427 15</org_study_id>
    <nct_id>NCT03312127</nct_id>
  </id_info>
  <brief_title>Evaluation of Peri-surgical Results at Short and Mean Terms of the GORE ® Excluder Iliac Branch Endoprosthesis</brief_title>
  <acronym>HYPOGRAFT</acronym>
  <official_title>Evaluation of Peri-surgical Results at Short and Mean Terms of the GORE ® Excluder Iliac Branch Endoprosthesis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Toulouse</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Toulouse</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this project is to demonstrate the benefit of the use of aortic iliac branch&#xD;
      endoprosthesis in the iliac aneurysms and to avoid the classic complications.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    End of inclusion period&#xD;
  </why_stopped>
  <start_date type="Actual">August 1, 2017</start_date>
  <completion_date type="Actual">July 26, 2018</completion_date>
  <primary_completion_date type="Actual">July 26, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Primary permeability maintenance of the iliac branch endoprosthesis, following its insertion (binary criterion)</measure>
    <time_frame>At the immediate post-operating follow-up visit</time_frame>
    <description>Primary permeability maintenance of the iliac branch endoprosthesis, following its insertion. It is a binary criterion (permeable or not) This criterion will be evaluated by a doppler ultrasound. These exams will be performed by a unique vascular physician, who will measure the hemodynamic criterions and the associated gluteal region oximetry.&#xD;
Endoprosthesis will be considered to be permeable if the patient is asymptomatic (absence of gluteal claudication), if Doppler ultrasound and angio-scan confirm the permeability of the endoprosthesis.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Primary permeability maintenance of the iliac branch endoprosthesis, following its insertion (binary criterion)</measure>
    <time_frame>at 3 months after surgery</time_frame>
    <description>Primary permeability maintenance of the iliac branch endoprosthesis, following its insertion. It is a binary criterion (permeable or not) This criterion will be evaluated by a doppler ultrasound. These exams will be performed by a unique vascular physician, who will measure the hemodynamic criterions and the associated gluteal region oximetry.&#xD;
Endoprosthesis will be considered to be permeable if the patient is asymptomatic (absence of gluteal claudication), if Doppler ultrasound and angio-scan confirm the permeability of the endoprosthesis.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Primary permeability maintenance of the iliac branch endoprosthesis, following its insertion (binary criterion)</measure>
    <time_frame>at 12 months after surgery</time_frame>
    <description>Primary permeability maintenance of the iliac branch endoprosthesis, following its insertion. It is a binary criterion (permeable or not) This criterion will be evaluated by a doppler ultrasound. These exams will be performed by a unique vascular physician, who will measure the hemodynamic criterions and the associated gluteal region oximetry.&#xD;
Endoprosthesis will be considered to be permeable if the patient is asymptomatic (absence of gluteal claudication), if Doppler ultrasound and angio-scan confirm the permeability of the endoprosthesis.&#xD;
Primary permeability will be considered non-maintained at 1 year if a stenosis &gt;70% or a thrombosis of the hypogastric branch is observed by ultra-sound scan at a follow-up visit during the first year after surgery or at a ultra-sound scan exam motivated by pelvic ischemia clinical signs</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Morbidity</measure>
    <time_frame>peri-operative, at short term (3 months), mean-term (12 months)</time_frame>
    <description>Evaluation of the morbidity:&#xD;
Minor events (no revision surgery needed):&#xD;
General: pulmonary, cardiologic, renal&#xD;
Local: hematoma, false aneurysm, Impaired wound healing&#xD;
Major events (revision surgery needed):&#xD;
Endoleak&#xD;
Thrombosis&#xD;
Rupture</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">3</enrollment>
  <condition>Iliac Aneurysm</condition>
  <arm_group>
    <arm_group_label>GORE Excluder</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>GORE Excluder Iliac Branch Endoprosthesis arm with 'ILIAC ENDOPROSTHESIS GORE EXCLUDER'</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ILIAC ENDOPROSTHESIS GORE EXCLUDER</intervention_name>
    <description>Set up of GORE ® Excluder Iliac Branch Endoprosthesis in endovascular barring of complex aneurysms without distal neck. In the immediate post-operating follow-up visit and at the 3 months visit and the 12 months visit after surgery, an ultra-sound scan, a tomodensitometric exam and a walking test on a treadmill with oximetric gluteal region exploration will systematically be performed.</description>
    <arm_group_label>GORE Excluder</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  High surgical risk:&#xD;
&#xD;
               -  Comorbidity cardiopulmonary&#xD;
&#xD;
               -  Renal insufficiency&#xD;
&#xD;
               -  Hostile abdomen including ascites or portal hypertension&#xD;
&#xD;
          -  Anatomic criteria:&#xD;
&#xD;
               -  Primitive iliac aneurysm superior to 25 mm without collar&#xD;
&#xD;
               -  Primitive iliac length superior to 40 mm&#xD;
&#xD;
               -  Primitive iliac distal diameter superior to 14 mm&#xD;
&#xD;
               -  Presence of internal iliac collar&#xD;
&#xD;
          -  Affiliation to a social security system&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient without surgical risk&#xD;
&#xD;
          -  Non-respect of the Anatomic criteria&#xD;
&#xD;
          -  Patient with known allergy to the materials of the device&#xD;
&#xD;
          -  Patient with systemic infection&#xD;
&#xD;
          -  Patient with severe renal insufficiency&#xD;
&#xD;
          -  Patient unable to complete the oximetry test&#xD;
&#xD;
          -  Persons under legal protection&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-Pierre BOSSAVY, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Toulouse</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital Toulouse</name>
      <address>
        <city>Toulouse</city>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>July 27, 2017</study_first_submitted>
  <study_first_submitted_qc>October 11, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 17, 2017</study_first_posted>
  <last_update_submitted>August 24, 2020</last_update_submitted>
  <last_update_submitted_qc>August 24, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 26, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Iliac Aneurysm</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

